ZimVie Inc. (NASDAQ:ZIMV) Short Interest Up 16.5% in February

ZimVie Inc. (NASDAQ:ZIMV) was the recipient of a large increase in short interest in the month of February. As of February 28th, there was short interest totalling 400,500 shares, an increase of 16.5% from the February 13th total of 343,900 shares. Currently, 1.5% of the shares of the company are sold short. Based on an average daily volume of 126,700 shares, the short-interest ratio is presently 3.2 days.

Analyst Upgrades and Downgrades

Separately, Needham & Company LLC restated a “hold” rating on shares of ZimVie in a research report on Thursday, March 13th.

Institutional Trading of ZimVie

A number of institutional investors have recently made changes to their positions in ZIMV. J. Goldman & Co LP boosted its holdings in shares of ZimVie by 167.5% during the 4th quarter. J. Goldman & Co LP now owns 1,425,810 shares of the company’s stock worth $19,890,000 after purchasing an additional 892,785 shares during the last quarter. American Century Companies Inc. grew its holdings in ZimVie by 23.9% in the 4th quarter. American Century Companies Inc. now owns 628,050 shares of the company’s stock valued at $8,761,000 after buying an additional 121,053 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in shares of ZimVie by 9.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,244,938 shares of the company’s stock worth $17,367,000 after acquiring an additional 107,461 shares during the last quarter. Mill Road Capital Management LLC purchased a new position in shares of ZimVie during the 4th quarter worth $1,401,000. Finally, Ancora Advisors LLC boosted its position in shares of ZimVie by 460.8% during the 4th quarter. Ancora Advisors LLC now owns 112,160 shares of the company’s stock valued at $1,565,000 after acquiring an additional 92,160 shares during the last quarter. 95.63% of the stock is owned by institutional investors and hedge funds.

ZimVie Stock Performance

NASDAQ ZIMV opened at $11.89 on Thursday. The stock has a market capitalization of $329.08 million, a price-to-earnings ratio of -0.91 and a beta of 2.10. The stock has a 50-day moving average of $13.39 and a 200 day moving average of $14.29. The company has a current ratio of 1.94, a quick ratio of 1.38 and a debt-to-equity ratio of 0.57. ZimVie has a twelve month low of $11.62 and a twelve month high of $22.40.

ZimVie (NASDAQ:ZIMV) last announced its earnings results on Wednesday, February 26th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.02. The business had revenue of $111.52 million during the quarter, compared to the consensus estimate of $113.67 million. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. Sell-side analysts anticipate that ZimVie will post 0.6 EPS for the current fiscal year.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.